Stephen J Ruoss
Overview
Explore the profile of Stephen J Ruoss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madhok J, ODonnell C, Jin J, Owyang C, Weimer J, Pashun R, et al.
J Cardiothorac Vasc Anesth
. 2024 Jul;
38(9):1885-1896.
PMID: 38960805
Objective: To evaluate the impact of inflammation on anticoagulation monitoring for patients supported with extracorporeal membrane oxygenation (ECMO). Design: Prospective single-center cohort study. Setting: University-affiliated tertiary care academic medical center....
2.
Hansra B, Rao V, Vogelsong M, Ruoss S
Respir Med Case Rep
. 2022 Aug;
39:101721.
PMID: 35965487
Extracorporeal membrane oxygenation (ECMO) is an invasive support strategy for cardiac, respiratory, or combined cardiorespiratory failure. ECMO has become increasing utilized in patients with severe respiratory failure due to COVID-19...
3.
Block J, Madhok J, Owyang C, Merriman K, Ruoss S, Rao V
Crit Care Explor
. 2021 Oct;
3(10):e0548.
PMID: 34671745
Objectives: Inhaled epoprostenol is a continuously delivered selective pulmonary vasodilator that is used in patients with refractory hypoxemia, right heart failure, and postcardiac surgery pulmonary hypertension. Published data suggest that...
4.
5.
Swenson K, Ruoss S, Swenson E
Ann Am Thorac Soc
. 2021 Feb;
18(7):1098-1105.
PMID: 33621159
The ongoing coronavirus disease (COVID-19) pandemic has been unprecedented on many levels, not least of which are the challenges in understanding the pathophysiology of these new critically ill patients. One...
6.
Giannikou K, Lasseter K, Grevelink J, Tyburczy M, Dies K, Zhu Z, et al.
Genet Med
. 2020 Dec;
23(10):2022.
PMID: 33353975
No abstract available.
7.
Winthrop K, Flume P, Thomson R, Mange K, Yuen D, Ciesielska M, et al.
Ann Am Thorac Soc
. 2020 Dec;
18(7):1147-1157.
PMID: 33326356
Patients with refractory complex (MAC) lung disease have limited treatment options. In the CONVERT study, amikacin liposome inhalation suspension (ALIS) added to guideline-based therapy (GBT) increased culture conversion rates versus...
8.
Giannikou K, Lasseter K, Grevelink J, Tyburczy M, Dies K, Zhu Z, et al.
Genet Med
. 2019 Jun;
21(11):2639-2643.
PMID: 31160751
Purpose: To examine the prevalence and spectrum of mosaic variant allele frequency (MVAF) in tuberous sclerosis complex (TSC) patients with low-level mosaicism and correlate genetic findings with clinical features and...
9.
Griffith D, Eagle G, Thomson R, Aksamit T, Hasegawa N, Morimoto K, et al.
Am J Respir Crit Care Med
. 2018 Sep;
198(12):1559-1569.
PMID: 30216086
Improved therapeutic options are needed for patients with treatment-refractory nontuberculous mycobacterial lung disease caused by complex (MAC). To evaluate the efficacy and safety of daily amikacin liposome inhalation suspension (ALIS)...
10.
Liu V, Winthrop K, Lu Y, Sharifi H, Nasiri H, Ruoss S
Ann Am Thorac Soc
. 2018 Sep;
15(10):1169-1176.
PMID: 30213194
Rationale: Nontuberculous mycobacterial (NTM) pulmonary disease prevalence is increasing. Objectives: To determine the association between the use of inhaled corticosteroids and the likelihood of NTM pulmonary infection among individuals with...